Vise Technologies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98M Buy
15,333
+2,335
+18% +$987K 0.07% 239
2026
Q1
$6.07M Hold
12,998
– – 0.12% 144
2025
Q4
$6.07M Buy
12,998
+1,892
+17% +$878K 0.12% 144
2025
Q3
$4.73M Sell
11,106
-26
-0.2% -$10.1K 0.18% 116
2025
Q2
$4.26M Buy
+11,132
New +$4.01M 0.18% 131
2024
Q4
$1.62M Buy
5,407
+3,580
+196% +$1.25M 0.14% 163
2024
Q3
$743K Buy
+1,827
New +$669K 0.09% 206
2022
Q2
– Sell
-3,828
Closed -$959K – 306
2022
Q1
$959K Sell
3,828
-10,158
-73% -$2.55M 0.36% 72
2021
Q4
$3.59M Buy
+13,986
New +$3.42M 0.97% 29

Other funds holding HCA

Vise Technologies's HCA Position: Q2 2026 in Review

Vise Technologies increased its HCA Healthcare (HCA) stake by 18% in Q2 2026, buying an estimated $987K and bringing the position to 15,333 shares worth $5.98M. The position accounts for 0.07% of the portfolio, ranked #239.

Vise Technologies first reported a position in HCA in Q4 2021 and has held it in 9 quarters since. The position peaked at $6.07M in Q1 2026. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Vise Technologies held 15,333 shares of HCA Healthcare worth $5.98M as of Q2 2026.
  • Vise Technologies bought 2,335 HCA Healthcare shares in Q2 2026, an estimated $987K.
  • HCA Healthcare made up 0.07% of Vise Technologies's portfolio in Q2 2026, its #239 holding.
  • Vise Technologies first reported a position in HCA Healthcare in Q4 2021 and has held it in 9 quarters since.
  • Vise Technologies's HCA Healthcare position peaked at $6.07M in Q1 2026.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.